Provexis (PXS)

Sector:

Food

Index:

FTSE AIM All-Share

0.60p
   
  • Change Today:
    -0.025p
  • 52 Week High: 0.81
  • 52 Week Low: 0.48
  • Currency: UK Pounds
  • Shares Issued: 2,262.95m
  • Volume: 6,150,360
  • Market Cap: £13.58m
  • RiskGrade: 364

Provexis says partnership will widen use of Fruitflow

By Josh White

Date: Friday 18 Nov 2016

LONDON (ShareCast) - (ShareCast News) - Developer of the Fruitflow heart-health functional food product, Provexis, announced on Friday that the company's alliance partner for Fruitflow, DSM Nutritional Products, has entered into a strategic collaboration agreement for Fruitflow with BY-HEALTH Co, a substantial listed Chinese dietary supplement business.
The AIM-traded firm said the strategic collaboration agreement between DSM and BY-HEALTH will focus on the development of new products that contribute to cardiovascular health, to include the establishment of relevant evaluation and testing procedures to accord with Chinese technical and regulatory standards.

It said the development process will target the creation of new products for people who are at risk of cardiovascular disease, particularly to include those over 40 years of age.

"There are already more than 230m people in China who are thought to have cardiovascular disease, and a significant increase in cardiovascular events is expected in China over the course of the next decade based on population aging and growth alone," its board said in a statement.

"The company believes that Fruitflow has the potential to play an import role in primary prevention in the Chinese market."

Provexis said the collaboration agreement was signed at the Guangzhou International Symposium on Nutrition and Health, which had the theme 'Nutrition and Chronic Diseases: New Development, New Challenges'.

The company's lead scientist Dr Niamh O'Kennedy, who played a key role in the development of Fruitflow, gave a presentation to the Guangzhou International Symposium concerning the cardiovascular benefits of Fruitflow.

Provexis said it will provide scientific and technical support for Fruitflow to DSM and BY-HEALTH throughout the collaboration.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Provexis Market Data

Currency UK Pounds
Share Price 0.60p
Change Today -0.025p
% Change -4.00 %
52 Week High 0.81
52 Week Low 0.48
Volume 6,150,360
Shares Issued 2,262.95m
Market Cap £13.58m
RiskGrade 364

Provexis Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
40.67% below the market average40.67% below the market average40.67% below the market average40.67% below the market average40.67% below the market average
62.96% below the sector average62.96% below the sector average62.96% below the sector average62.96% below the sector average62.96% below the sector average
Price Trend
0.52% below the market average0.52% below the market average0.52% below the market average0.52% below the market average0.52% below the market average
3.7% below the sector average3.7% below the sector average3.7% below the sector average3.7% below the sector average3.7% below the sector average
Income Not Available
Growth
46.68% below the market average46.68% below the market average46.68% below the market average46.68% below the market average46.68% below the market average
48.15% below the sector average48.15% below the sector average48.15% below the sector average48.15% below the sector average48.15% below the sector average

Provexis Dividends

No dividends found

Trades for 04-Jun-2024

Time Volume / Share Price
16:12 2,896,200 @ 0.55p
16:12 2,919,160 @ 0.55p
09:20 150,000 @ 0.58p
08:00 185,000 @ 0.58p

Provexis Key Personnel

CEO Ian Ford

Top of Page